Table 4 Comparison between patients’ subgroups 1 and 2 as regards hyaluronic acid (HA) ng/ml in the three visits
From: Assessment of hyaluronic acid in COPD patients as a prognostic biomarker
Hyaluronic acid (HA) ng/ml | Groups | Test of sig | ||
|---|---|---|---|---|
Subgroup 1 (no. = 30) | Subgroup 2 (no. = 30) | U | p-value | |
Visit 1 | 269.33 ± 42.58 | 290 ± 43.07 | 336.5 | 0.007* |
Visit 2 | 221 ± 40.97 | 248 ± 42.21 | 296 | 0.020* |
Visit 3 | 163.33 ± 29.63 | 190.67 ± 31.28 | 215 | 0.000** |
P1 | 0.000** | 0.000** | ||
P2 | 0.000** | 0.000** | ||
P3 | 0.000** | 0.000** | ||